Colgate-Palmolive (NYSE:CL) Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. raised its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 4.9% in the third quarter, Holdings Channel.com reports. The fund owned 997,147 shares of the company’s stock after buying an additional 46,944 shares during the quarter. Principal Financial Group Inc.’s holdings in Colgate-Palmolive were worth $103,514,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. DGS Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 35.9% during the 3rd quarter. DGS Capital Management LLC now owns 8,625 shares of the company’s stock worth $895,000 after acquiring an additional 2,280 shares in the last quarter. Garde Capital Inc. boosted its position in Colgate-Palmolive by 19.5% during the third quarter. Garde Capital Inc. now owns 1,553 shares of the company’s stock worth $161,000 after purchasing an additional 253 shares in the last quarter. Peapack Gladstone Financial Corp grew its holdings in Colgate-Palmolive by 2.4% in the third quarter. Peapack Gladstone Financial Corp now owns 50,653 shares of the company’s stock valued at $5,258,000 after purchasing an additional 1,203 shares during the last quarter. Tidal Investments LLC increased its position in shares of Colgate-Palmolive by 351.0% in the third quarter. Tidal Investments LLC now owns 284,568 shares of the company’s stock valued at $29,541,000 after buying an additional 221,469 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB raised its stake in shares of Colgate-Palmolive by 125.0% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 51,333 shares of the company’s stock worth $5,329,000 after buying an additional 28,518 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $92.03 on Friday. The business’s fifty day moving average price is $95.02 and its 200 day moving average price is $98.61. The stock has a market capitalization of $75.19 billion, a P/E ratio of 26.37, a PEG ratio of 3.31 and a beta of 0.43. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $76.96 and a twelve month high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.34% of the stock is currently owned by insiders.

Analysts Set New Price Targets

CL has been the subject of several recent research reports. UBS Group raised their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Piper Sandler assumed coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price target for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Finally, Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $105.11.

Get Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.